
To address the limited regional evidence on diabetic bone disease, this study estimated the prevalence of DEXA-defined osteopenia and osteoporosis in a DEXA-referred cohort and identified predictors of low bone mineral density among Jordanian adults with type 2 diabetes mellitus (T2DM). This cross-sectional study was conducted at the University of Jordan Hospital, Amman, Jordan, between January 2022 and March 2025. A total of 253 adults with T2DM who underwent dual-energy X-ray absorptiometry (DEXA) within the preceding six months were included. Bone mineral density was classified according to World Health Organization T-score criteria based on the complete DEXA examination, including the lumbar spine, femoral neck, and total hip, as documented in the radiology reports. Clinical, biochemical, diabetes-related, and medication-associated variables were compared across BMD categories. Independent predictors of osteopenia and osteoporosis were assessed using multivariable multinomial logistic regression. Low bone mass was highly prevalent: 52.6
Rhabdomyolysis is a potentially life-threatening syndrome caused by skeletal muscle breakdown and release of intracellular components, including creatine kinase (CK) and myoglobin, into the circulation. Although hypothyroidism and severe hypokalemia are both recognized but uncommon causes of rhabdomyolysis, their coexistence creates diagnostic challenges in determining the underlying mechanisms of muscle injury. A 51-year-old postmenopausal woman presented with fatigue, myalgia, limb weakness, nausea, poor appetite, and palpitations for 18 days, with worsening symptoms over the preceding four days. Laboratory evaluation revealed severe Hashimoto’s thyroiditis (thyroid-stimulating hormone > 100 µIU/mL, free thyroxine 8.51 pmol/L, anti-thyroid peroxidase antibody > 1000 IU/mL), profound hypokalemia (1.53–2.15 mmol/L), metabolic alkalosis, and rhabdomyolysis (CK 7207 U/L, myoglobin 3823 ng/mL, lactate dehydrogenase 769 U/L). Evaluation of the hypokalemia, including 24-hour urinary electrolyte analysis and measurements of renin and aldosterone, was performed after potassium replacement and intravenous fluid therapy and therefore did not definitively establish the presence or absence of renal potassium wasting. No other common precipitants of rhabdomyolysis were identified during the clinical evaluation. The patient improved following intravenous fluid therapy, potassium replacement, and levothyroxine treatment. This case illustrates the diagnostic complexity of severe rhabdomyolysis occurring in the setting of concurrent Hashimoto’s thyroiditis and profound hypokalemia. It highlights the paradoxical coexistence of rhabdomyolysis with severe potassium depletion and emphasizes the importance of simultaneously evaluating endocrine and electrolyte abnormalities in patients with unexplained muscle injury. The case also contributes to the limited clinical evidence regarding the potential interaction between hypothyroidism and severe hypokalemia in the development of skeletal muscle injury.
Insulin resistance (IR) is often underrecognized in young adults with type 1 diabetes (T1D). The aim of this study was to characterize metabolic and body-composition features associated with IR using complementary clinical, biological, and DXA-derived measures and to investigate their associations with diabetic retinopathy (DR) in young adults with T1D. We conducted a case-control study involving 68 patients with T1D and 68 controls matched for age, sex, and body mass index, aged between 18 and 45 years. Estimated Glucose Disposal Rate (eGDR) was calculated as a measure of IR in patients with T1D. Acanthosis nigricans, metabolic syndrome (MS) components, and DXA-derived measures of body fat distribution were assessed in both groups. Clinical and biological parameters, eGDR and DXA-derived body fat characteristics were compared between T1D patients with and without DR. Multivariable logistic regression analyses were performed to examine the associations of eGDR and DXA-derived visceral fat mass proportion (
The gut-bone axis has emerged as an important framework for understanding the interplay among intestinal homeostasis, microbial metabolism, immune regulation, and bone remodeling in osteoporosis. As the literature has expanded rapidly, a descriptive bibliometric assessment is needed to clarify publication patterns, major hotspots, and emerging thematic directions. Publications were retrieved from the Web of Science Core Collection, PubMed, and China National Knowledge Infrastructure from database inception to February 28, 2026. After database-specific screening and cross-database deduplication, 446 publications were retained in the final corpus. The analysis examined annual publication trends, citation indicators available within the screened Web of Science Core Collection subset, source journals, contributing countries and institutions, recurrent authors, and rule-based thematic structure. The descriptive scope and metadata-related limitations of cross-database analyses were explicitly considered. The final corpus comprised 399 unique English-language records from the Web of Science Core Collection and PubMed, together with 47 Chinese records from China National Knowledge Infrastructure. Publication output increased sharply after 2019 and peaked in 2025. The screened Web of Science Core Collection subset showed a distinct citation backbone centered on sex steroid deficiency-associated bone loss, probiotic intervention, gut microbiota alteration, and microbial metabolite-mediated mechanisms. China and the United States were the leading contributing countries, and Shanghai Jiao Tong University School of Medicine was the most productive institution. Leading source journals included Frontiers in Cellular and Infection Microbiology, Frontiers in Endocrinology, Frontiers in Microbiology, and China Osteoporosis Journal. Thematic analysis identified gut microbiota and dysbiosis, osteoporosis and bone remodeling, microbial metabolites and short-chain fatty acids, immune and barrier regulation, and microecological intervention as the dominant themes. Research on the gut-bone axis in osteoporosis has rapidly developed into a distinct interdisciplinary field. This study provides a structured descriptive overview of publication patterns, citation influence, and thematic evolution, and highlights mechanistic, computational, and translational directions that may inform future work.
Muscle mass and fat mass are central determinants of metabolic health, physical function, and disease risk. While higher muscle mass supports longevity and energy metabolism, excess fat mass—particularly visceral fat—predisposes individuals to chronic diseases. Diet quality, reflected by the Healthy Eating Index-2015 (HEI-2015), integrates adequacy (intake of beneficial foods) and moderation (limitation of harmful foods). This study examined how HEI-2015 adequacy and moderation relate specifically to muscle mass, fat mass, and lipid profile among Iranian health workers. In this cross-sectional analysis of 3,381 participants aged 20–70 years from the Shiraz University of Medical Sciences Employees Health Cohort Study (SUMS-EHCS), dietary intake was assessed using a validated 168-item food frequency questionnaire. HEI-2015 adequacy and moderation scores were calculated, and body composition—including fat mass, fat-free mass, skeletal muscle mass, and trunk fat mass—was measured using bioelectrical impedance analysis. Fasting blood glucose and lipid parameters were assessed from fasting blood samples. Associations of HEI-2015, adequacy, and moderation scores with body composition, lipid parameters, and fasting blood glucose were examined using multivariable linear regression models adjusted for demographic, lifestyle, and metabolic covariates. The mean HEI score was 63.9 ± 9.5, reflecting moderate diet quality. After adjustment, higher HEI-2015 scores were associated with greater fat-free mass (β = 0.043, 95